Explore our newsroom for Symani press releases, news stories, and journalist resources.
Stay up to date with the latest Symani news
Subscribe for timely email updates from MMI
"*" indicates required fields

MMI to Present at 43rd Annual J.P. Morgan Healthcare Conference

Cedars-Sinai secures research funding to develop eye transplantation procedures to cure blindness

St. Vincent’s Hospital in Melbourne is first health system in Australia to adopt robotic-assisted microsurgery with Symani

MMI’s Symani® Surgical System Named a TIME Best Invention of 2024

Patient story highlights new possibilities in breast cancer-related lymphedema with the help of robotic-assisted microsurgery

Transforming breast reconstruction: The role of robotic-assisted surgery in the breast cancer journey

MMI Completes World’s First Robotic Preclinical Study in Neurosurgery with Symani® Surgical System

What’s next for surgical robotics? Medtech vet Mark Toland places his bets

MMI Builds Global Momentum with Multiple Distribution Agreements and Regulatory Approvals

MMI Wins Innovative Start-up in 2024 Surgical Robotics Industry Awards

Robot-assisted surgery: Big step in the millimeter range

MMI Completes First Symani® Clinical Cases in the U.S. Following FDA Commercial Authorization
5022 Gate Parkway,
Building 500,
Jacksonville, FL 32256
The Symani Surgical System is authorized for use in the U.S. by the FDA and is a CE marked medical device. Clinical indications vary by geography. Refer to global indications for more information. © 2024 Medical Microinstruments, Inc. All Rights Reserved.